Total Payments
$814.40
2023 Payments
$13.60
Companies
16
Transactions
45
Medicare Patients
2,269
Medicare Billing
$364,453
Payment Breakdown by Category
Food & Beverage$658.01 (80.8%)
Education$156.39 (19.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $658.01 | 40 | 80.8% |
| Education | $156.39 | 5 | 19.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $176.49 | 7 | $0 (2019) |
| Amgen Inc. | $129.23 | 8 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $76.83 | 4 | $0 (2021) |
| Horizon Therapeutics plc | $61.89 | 3 | $0 (2021) |
| Relypsa, Inc. | $56.35 | 4 | $0 (2020) |
| Vifor Pharma, Inc. | $53.89 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $48.58 | 3 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $46.05 | 3 | $0 (2021) |
| Avenu Medical Inc. | $34.25 | 1 | $0 (2020) |
| Mallinckrodt LLC | $29.99 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.60 | 1 | Calliditas Therapeutics US Inc. ($13.60) |
| 2022 | $12.14 | 1 | Vifor Pharma, Inc. ($12.14) |
| 2021 | $252.84 | 14 | Horizon Therapeutics plc ($61.89) |
| 2020 | $78.40 | 4 | Avenu Medical Inc. ($34.25) |
| 2019 | $74.27 | 5 | Genentech USA, Inc. ($29.73) |
| 2018 | $206.43 | 8 | Genentech USA, Inc. ($120.92) |
| 2017 | $176.72 | 12 | Amgen Inc. ($31.90) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 06/13/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 12/02/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $14.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: KRYSTEXXA | ||||||
| 11/18/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Nephrology | ||||||
| 10/21/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Nephrology | ||||||
| 10/06/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Immunology | ||||||
| 09/14/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Hyperkalemia | ||||||
| 09/09/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: KRYSTEXXA | ||||||
| 08/02/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Nephrology | ||||||
| 07/27/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.65 | General |
| Category: NEPHROLOGY | ||||||
| 07/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/23/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Hyperkalemia | ||||||
| 05/27/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/18/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/05/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: KRYSTEXXA | ||||||
| 10/14/2020 | Avenu Medical Inc. | Ellipsys (Device) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: Catheters | ||||||
| 08/13/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Hyperkalemia | ||||||
| 06/15/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEPHROLOGY | ||||||
| 03/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: NEPHROLOGY | ||||||
| 11/05/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Nephrology | ||||||
| 10/15/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Hyperkalemia | ||||||
| 08/06/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: BioOncology/Immunology | ||||||
| 06/18/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology | ||||||
| 01/15/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 152 | 229 | $60,307 | $17,754 |
| 2022 | 9 | 497 | 818 | $261,478 | $73,642 |
| 2021 | 12 | 750 | 7,875 | $477,551 | $133,338 |
| 2020 | 14 | 870 | 12,729 | $526,267 | $139,720 |
Total Patients
2,269
Total Services
21,651
Medicare Billing
$364,453
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 86 | $16,340 | $5,316 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 52 | $14,144 | $4,965 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $8,480 | $2,115 | 24.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 19 | 33 | $6,369 | $1,876 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $9,230 | $1,787 | 19.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,744 | $1,695 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 194 | $52,768 | $15,899 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 218 | $41,522 | $12,372 | 29.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 62 | $32,958 | $9,864 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 55 | 55 | $33,055 | $9,455 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 99 | $34,479 | $8,186 | 23.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 50 | 109 | $21,037 | $6,300 | 29.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 20 | 35 | $26,361 | $6,045 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $13,195 | $3,706 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $6,103 | $1,815 | 29.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 145 | $128,760 | $39,962 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 341 | $114,917 | $30,613 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 328 | 406 | $94,192 | $23,250 | 24.7% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2021 | 12 | 6,595 | $46,165 | $17,272 | 37.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $44,283 | $10,208 | 23.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 19 | $11,932 | $2,959 | 24.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 25 | $10,700 | $2,639 | 24.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 45 | $10,080 | $2,516 | 25.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $9,990 | $2,258 | 22.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 84 | $3,696 | $931.56 | 25.2% |
About Dr. Anjali Gupta, MD
Dr. Anjali Gupta, MD is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104074715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anjali Gupta, MD has received a total of $814.40 in payments from pharmaceutical and medical device companies, with $13.60 received in 2023. These payments were reported across 45 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($658.01).
As a Medicare-enrolled provider, Gupta has provided services to 2,269 Medicare beneficiaries, totaling 21,651 services with total Medicare billing of $364,453. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Roseburg, OR
- Active Since 09/08/2008
- Last Updated 11/10/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104074715
Products in Payments
- Rituxan (Biological) $176.49
- Veltassa (Drug) $98.10
- KRYSTEXXA (Biological) $61.89
- Rayaldee (Drug) $46.18
- LOKELMA (Drug) $36.65
- Parsabiv (Drug) $36.40
- Ellipsys (Device) $34.25
- Prolia (Biological) $31.90
- Parsabiv (Biological) $31.05
- RAYALDEE (Drug) $30.65
- ACTHAR (Biological) $29.99
- Repatha (Biological) $29.88
- SOLIRIS (Drug) $29.13
- JYNARQUE (Drug) $29.06
- NORTHERA (Drug) $16.96
- Ultomiris (Drug) $16.92
- Auryxia (Drug) $16.65
- AVYCAZ (Drug) $13.97
- TARPEYO (Drug) $13.60
- FARXIGA (Drug) $11.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseburg
William Townsend, Md, MD
Internal Medicine — Payments: $3,059
Internal Medicine $3,059
Dr. Mohamed Abdel Khalek, M.d, M.D
Internal Medicine — Payments: $1,602
Internal Medicine $1,602
Lorrie Oksenholt, Do, DO
Internal Medicine — Payments: $1,576
Internal Medicine $1,576
Joel Lee, Md, MD
Internal Medicine — Payments: $1,275
Internal Medicine $1,275
Doru Totoian, Md, MD
Internal Medicine — Payments: $1,266
Internal Medicine $1,266
Dr. Hennie Abrio, Md, MD
Internal Medicine — Payments: $970.03
Internal Medicine $970.03